Foley Hoag LLP publishes this quarterly Update primarily concerning developments in product liability and related law from federal and state courts applicable to Massachusetts, but also featuring selected developments for New York and New Jersey. If you find this update useful, please encourage your colleagues.
Included in this Issue:
MASSACHUSETTS -
- Massachusetts Federal Court Holds Federal Food, Drug, And Cosmetic Act Preempts Failure-To-Warn Claim Against Migraine Drug Manufacturers Because FDA Approved Label Knowing Who Was Excluded From Clinical Testing And No Newly Acquired Information Permitted Defendants To Unilaterally Modify Label Under FDA’s “Changes Being Effected” Regulation...
Please see full publication below for more information.
